文献速递生殖医学

比较玻璃化冷冻胚胎时使用泥状氮与液氮的随机对照试验:胚胎学与临床结局

A randomized controlled trial comparing embryo vitrification with slush nitrogen to liquid nitrogen in women undergoing frozen embryo transfer: embryology and clinical outcomes.
PubMed 文献 · Hum Reprod · 2025-01-01

该随机对照试验纳入253例接受体外受精刺激的患者,比较泥状氮(SN)与液氮(LN)玻璃化冷冻胚胎的效果。预试验显示SN组囊胚平均存活玻璃化-复温循环数7.5次显著高于LN组3.0次(P<0.0001)。单次冻融移植后两组妊娠结局无显著差异,因无效分析提前终止。

要点

  • SN组囊胚平均存活7.5次玻璃化-复温循环,显著高于LN组3.0次(P<0.0001)。
  • 单次冻融移植后两组妊娠率、临床妊娠率、持续着床率和流产率无显著差异。
  • SN是安全的胚胎玻璃化替代方法,但未改善单次冻融移植的妊娠结局。

核心结论

  • SN是安全的胚胎玻璃化保存方法,在反复玻璃化-复温循环中显著提高复温后存活率,但单次冻融移植后妊娠结局未优于LN。

研究设计与样本

  • 预试验每组50枚捐赠胚胎评估反复冻融后存活,随后进行随机对照试验,2020年9月至2022年1月纳入253例患者,245例进入IVF刺激并至少获得1枚囊胚冻存,121例分配至SN组,124例分配至LN组。
  • 随机化在囊胚活检日采用计算机生成区组方案,通过不透明信封由胚胎学家在玻璃化日分配,患者、医生和临床团队对干预设盲。
  • 纳入标准为18至42岁女性,在大学附属不孕中心接受IVF刺激,计划进行植入前非整倍体遗传学检测并随后行单次冻融胚胎移植。

主要发现

  • 预试验显示SN组囊胚平均存活7.5次玻璃化-复温循环(范围3-22),显著高于LN组平均3.0次(范围0-10)(P<0.0001)。
  • 223例随机分配至SN或LN的患者接受单次冻融胚胎移植,两组基线特征及胚胎学结局(获卵数、成熟卵母细胞数、受精率、活检囊胚总数)相似。
  • 两组妊娠率、临床妊娠率、持续着床率和流产率无显著差异(P分别为0.16、0.80、0.49和0.74,采用Student t检验)。
  • 无效分析表明继续招募无价值,研究因此关闭。

临床怎么用

  • 作者认为SN是传统LN玻璃化的安全替代方法,但未证明可改善冻融胚胎的生殖潜能。

局限性

  • 未评估新生儿或出生结局。
  • 基于无效分析终止研究,无法得出SN与LN等效的结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does the use of slush nitrogen (SN) for embryo vitrification improve embryo transfer outcomes compared to liquid nitrogen (LN)? SUMMARY ANSWER: SN is a safe method for embryo preservation and significantly improves post-warming survival rates during repeated vitrification-warming cycles; however, after a single freeze-thaw cycle, pregnancy outcomes are not improved when embryos are vitrified with SN compared to LN. WHAT IS KNOWN ALREADY: SN is a combination of solid and LN, with a temperature lower than regular LN, and it is an alternative to conventional LN in achieving a faster cooling speed. Studies have shown that SN improves survival in non-human embryos and human oocytes. However, it is unknown whether the use of SN reduces blastocyst damage in humans during vitrification-as indicated by increased survival across multiple vitrification-warming cycles-or whether it enhances pregnancy outcomes in a single vitrification-warming cycle. STUDY DESIGN, SIZE, DURATION: Following the pre-clinical trial assessing embryo survival after repeated freeze-thaw cycles using SN and LN on 50 donated embryos per group, a randomized controlled trial was performed, where 253 patients were enrolled between September 2020 and January 2022, and 245 underwent an IVF stimulation, which resulted in at least one blastocyst for cryopreservation. Of those, 121 were allocated to the SN (study), and 124 were allocated to the LN (control) group. Randomization occurred on the day of blastocyst biopsy using a computer-generated block schema. Groups were assigned via opaque envelopes, opened by the embryologist on vitrification day. The patient, physician, and clinical team were blinded to the intervention. PARTICIPANTS/MATERIALS, SETTING, METHODS: All couples with female aged between 18 and 42 years old undergoing IVF stimulation at one university-affiliated infertility center, with plan for preimplantation genetic testing for aneuploidy and subsequent single, frozen embryo transfer (FET) were eligible for inclusion in this study. MAIN RESULTS AND THE ROLE OF CHANCE: The pre-clinical trial demonstrated significant improvements in blastocyst survival, with the SN group achieving a mean of 7.5 survived vitrification-warming cycles (range: 3-22), significantly surpassing the mean of 3.0 cycles (range: 0-10) in the LN group (P < 0.0001). Following the pre-clinical trial, 223 patients randomized to SN or LN underwent single FET. Baseline characteristics were similar between groups, as were embryology outcomes, including the number of oocytes retrieved, mature oocytes, fertilization rate, and total blastocysts biopsied. No significant differences were observed between the two groups in pregnancy rate, clinical pregnancy rate, sustained implantation rate, or miscarriage rate (P = 0.16, 0.80, 0.49, and 0.74, respectively, using Student's t-test). A futility analysis indicated no value in continuing recruitment and therefore the study was closed. LIMITATIONS, REASONS FOR CAUTION: Neonatal or birth outcomes were not assessed. Termination of the study based on futility analysis precludes a conclusion of equivalence between SN and LN. WIDER IMPLICATIONS OF THE FINDINGS: This study demonstrates that SN is a safe alternative to traditional LN for vitrification; however, it did not demonstrate improvements in the reproductive potential of vitrified embryos. STUDY FUNDING/COMPETING INTEREST(S): The project was funded by the Foundation for Embryonic Competence. TRIAL REGISTRATION NUMBER: NCT04496284. TRIAL REGISTRATION DATE: 3 August 2020. DATE OF FIRST PATIENT’S ENROLLMENT: 5 September 2020.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Klimczak AM, Osman E, Esbert M, et al. A randomized controlled trial comparing embryo vitrification with slush nitrogen to liquid nitrogen in women undergoing frozen embryo transfer: embryology and clinical outcomes. Hum Reprod. 2025. PMID: 39836897. doi:10.1093/humrep/deaf003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。